Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Lunedì 17 luglio 2023
circa 1 minuti di lettura
Journal and Affiliations:
Journal of Hepatology, 17 luglio 2023
Elisabetta Cameroni, Humabs Biomed, Bellinzona
Fabio Benigni, Humabs Biomed, Bellinzona
Fabrizia Zatta, Humabs Biomed, Bellinzona
Siro Bianchi, Humabs Biomed, Bellinzona
Gloria Lombardo, Humabs Biomed, Bellinzona
Stefano Jaconi, Humabs Biomed, Bellinzona
Lucia Vincenzetti, Humabs Biomed, Bellinzona
Nadia Passini, Humabs Biomed, Bellinzona
Davide Corti, Humabs Biomed, Bellinzona
Michael A. Schmid, Humabs Biomed, Bellinzona
Tags:
anti-HBs
chronic infection
HBsAg
Hepatitis B virus (HBV)
Hepatitis delta virus (HDV)
human liver chimeric mice
monoclonal antibody (mAb)
neutralization
virus spread
Authors:
Davide Corti
Elisabetta Cameroni
Fabio Benigni
Fabrizia Zatta
Gloria Lombardo
Lucia Vincenzetti
Michael A. Schmid
Nadia Passini
Siro Bianchi
Stefano Jaconi